NKG2D ligand (stress ligand) on tumor cell (NKG2D ligand (no standard single abbreviation; subtypes: MICA, MICB, ULBP1–6))

NKG2D ligands, also known as stress ligands or induced-self antigens, refer to a family of cell surface proteins upregulated by various cellular stresses, including DNA damage, oncogenic transformation, and infection. These ligands—mainly MHC class I chain-related proteins (MICA, MICB) and the UL16-binding protein family (ULBP1–6), among others—serve as danger signals for the immune system. They are recognized by the activating NKG2D receptor on natural killer (NK) cells and some T cell subsets, which initiate cytotoxic responses to eliminate abnormal or transformed cells, particularly tumor cells. Under physiological conditions, these ligands have low or absent expression on healthy cells to avoid autoimmunity; however, their aberrant or induced expression is a marker of cellular distress. As such, NKG2D ligands are active targets for cancer immunotherapy, but clinical translation is complicated by tumor evasion strategies (e.g., ligand shedding), potential off-tumor effects, and the complexity of tumor microenvironments. Their presence can serve as both a therapeutic target to enhance anti-tumor immunity and as a biomarker for disease progression and response to immune-based therapies.

Other names

Tumor-associated antigenStress ligandInduced-self antigenNKG2D ligandMICAMICBULBP1ULBP2ULBP3ULBP4RAET1GRAET1L

Immune cell-mediated cytotoxicity via recognition by NKG2D receptor on NK cells and some T cells. Targeted immune activation leading to tumor cell lysis